Press Release
Industry

Japan Intravenous Immunoglobulin for Myasthenia Gravis Market – An Insight on the Important Factors and Trends Influencing the Market

KD Market Insights offers a latest published report on Japan Intravenous Immunoglobulin for Myasthenia Gravis Market which is expected to grow at a CAGR (Compound Annual Growth Rate) of 7.5% between 2019–2024. In terms of value, the market that is worth the USD 19.4 million in 2018 and is anticipated to be worth the USD 29.7 million by 2024. A spoolable pipe is a flexible pipe composed of three layers, namely, the liner, cover, and reinforcement layer. The number of patients with late-onset myasthenia gravis (MG) ≥50 years has been increasing recently. This factor is anticipated to impel the growth of Japan intravenous immunoglobulin for myasthenia gravis market during the forecast period.

The rise in the prevalence of myasthenia gravis in Japan is envisioned to bolster the growth of the market during the forecast period. In Japan, the estimated number of patients with myasthenia gravis in 2006 was 15,100; giving a prevalence of 11.8 per 1,00,000 persons. Further, number of patients and prevalence rate has witnessed increase in the past few years. This factor is envisioned to bolster the growth of the market in the years ahead.

Request for Sample @ https://www.kdmarketinsights.com/sample/5211 
 
Growth in Diagnosis of Myasthenia Gravis
Rising diagnosis of myasthenia gravis patients in Japan is driving the demand for intravenous immunoglobulin. Moreover, the market stands to benefit from growing investments and development of specific tests for the diagnosis of myasthenia gravis. Furthermore, pending new approvals in disease indications is believed to positively impact the growth of the market.

Launch of New & Improved Version of Drugs
Factor such as strong pipeline, increased focus on R&D, raising awareness and adoption of novel therapies are driving the growth of Japan intravenous immunoglobulin market for myasthenia gravis. Various pharmaceutical firms are engaged in extensive research and development activities for efficient therapeutics for myasthenia gravis diseases. Furthermore, various clinical trials are being carried which is expected to bring advanced therapeutics for the people.

Barriers in Japan IVIG in Myasthenia Gravis Market
Increasing Cost of IVIG
Continuous increase in the price of IVIG per/gram is one of the major factors which are hindering the growth of the Japan intravenous immunoglobulin for myasthenia gravis Market. Since 2011, the price of intravenous immunoglobulin has increased to about 100%. Further, it is believed that increasing cost of IVIG might will result in weak demand for the short term.

Less Awareness of Myasthenia Gravis
Low awareness regarding symptoms of myasthenia gravis is another factor which is negatively impacting the growth of Japan intravenous immunoglobulin for myasthenia gravis market in the short term. However, government and various organizations are working to increase awareness of myasthenia gravis within key communities including patients, caregivers, medical professionals, and the general public.

Browse Full Report with TOC @ https://www.kdmarketinsights.com/product/japan-intravenous-immunoglobulin-myasthenia-gravis-market

Table of Contents:

Research Methodology
Market Definition and List of Abbreviations

1. Executive Summary
2. Growth Drivers & Barriers in Japan Intravenous Immunoglobulin for Myasthenia Gravis Market
3. Japan Intravenous Immunoglobulin Market Trends
4. Opportunities in Japan Intravenous Immunoglobulin Market
5. Porter’s Five Forces Analysis
6. Market Value Chain and Supply Chain Analysis
7. Japan Intravenous Immunoglobulin for Myasthenia Gravis Market Value (USD Million), Market Volume (Kilogram) Forecast & Y-o-Y Growth Analysis, 2018-2024

8. Japan Intravenous Immunoglobulin for Myasthenia Gravis Market Segmentation Analysis, By End User
8.1. Introduction
8.2. Market Attractiveness, By End User
8.3. BPS Analysis, By End User
8.4. Hospital Market Value (USD Million), Market Volume (Kilogram) Forecast & Y-o-Y Growth Analysis, 2018-2024
8.5. Clinic Market Value (USD Million), Market Volume (Kilogram) Forecast
& Y-o-Y Growth Analysis, 2018-2024
8.6. Home Care Market Value (USD Million), Market Volume (Kilogram) Forecast & Y-o-Y Growth Analysis, 2018-2024

9. Competitive Landscape
9.1. Company Profiles
9.1.1.CSL Behring
9.1.2.Pfizer Inc.
9.1.3.Grifols
9.1.4.Baxter
9.1.5.Takeda Pharmaceutical Company Limited
Continue….
 
Check for Discount @ https://www.kdmarketinsights.com/discount/5211 

About Us:

KD Market Insights offers a comprehensive database of syndicated research studies, customized reports, and consulting services. These reports are created to help in making smart, instant and crucial decisions based on extensive and in-depth quantitative information, supported by extensive analysis and industry insights. Our dedicated in-house team ensures the reports satisfy the requirement of the client. We aim at providing value service to our clients. Our reports are backed by extensive industry coverage and is made sure to give importance to the specific needs of our clients. The main idea is to enable our clients to make an informed decision, by keeping them and ourselves up to date with the latest trends in the market.

Contact Us:
 
KD Market Insights
150 State Street, Albany,
New York, USA 12207
+1 (518) 300-1215
Email: [email protected]
Website: www.kdmarketinsights.com
Read More News: https://marketnewsbizz.com
https://marketresearchtab.com
https://kdmarketinsightsblog.com